Chemotherapy and vitamin D supplement use are determinants of serum 25-hydroxyvitamin D levels during the first six months after colorectal cancer diagnosis

Evertine Wesselink*, Martijn J. L. Bours, Johannes H. W. de Wilt, Michiel Aquarius, Stephanie O. Breukink, Bibi Hansson, Eric T. P. Keulen, Dieuwertje E. Kok, Jody van den Ouweland, Eline H. van Roekel, Merel Snellen, Renate Winkels, Renger F. Witkamp, Moniek van Zutphen, Matty P. Weijenberg, Ellen Kampman, Franzel J. B. van Duijnhoven

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number105577
Number of pages10
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume199
DOIs
Publication statusPublished - May 2020

Keywords

  • serum 25(OH)D-3
  • Vitamin D
  • Colorectal cancer
  • Patients
  • Changes over time
  • Lifestyle and clinical determinants
  • QUALITY-OF-LIFE
  • D DEFICIENCY
  • SURVIVAL
  • STYLE
  • POPULATION
  • MORTALITY
  • HEALTH
  • SUN

Cite this